Panaxium
Panaxium is a bioelectronic medicine company pioneering a precision therapy brain-machine interface (BMI) platform designed to treat brain injuries such as stroke and traumatic brain injury. Their iontronic interface technology safely and selectively communicates with brain cells to direct precision healing, supported by proprietary AI-assisted MRI protocols that generate patient-specific functional brain network maps to guide personalized implantation and therapy planning. The company collaborates with leading neurosurgeons, neurologists, and researchers worldwide and is advancing preclinical studies in Europe and North America, aiming to enable patients to recover normal function and reduce life-altering disabilities. Panaxium's approach integrates advanced bioelectronics, machine learning, and neuroscience to create a revolutionary neuro-recovery therapy with potential to transform brain injury treatment at scale.
Panaxium
Panaxium is a bioelectronic medicine company pioneering a precision therapy brain-machine interface (BMI) platform designed to treat brain injuries such as stroke and traumatic brain injury. Their iontronic interface technology safely and selectively communicates with brain cells to direct precision healing, supported by proprietary AI-assisted MRI protocols that generate patient-specific functional brain network maps to guide personalized implantation and therapy planning. The company collaborates with leading neurosurgeons, neurologists, and researchers worldwide and is advancing preclinical studies in Europe and North America, aiming to enable patients to recover normal function and reduce life-altering disabilities. Panaxium's approach integrates advanced bioelectronics, machine learning, and neuroscience to create a revolutionary neuro-recovery therapy with potential to transform brain injury treatment at scale.